Rainbow Children's Medicare Ltd is a leading pediatric and maternal healthcare provider operating on a hub-and-spoke model, and it enters this quarter's print with revenue growth accelerating sharply even as EBITDA margins have stepped down for four straight quarters. The key things the results will speak to are the margin trajectory against management's 24%-25% pre-Ind AS target by end-FY27, and whether occupancy can close the gap toward the 56%-58% desirable range in a seasonally strong quarter that followed a deficit monsoon.
| Results date | October 31, 2026 |
|---|---|
| Quarter | Q2 FY 2026-2027 |
| Previous quarter revenue | Rs. 4,699.85 Mn (Rs. 470.0 Cr), +33.2% YoY |
| Previous quarter PAT | Rs. 625.40 Mn (Rs. 62.5 Cr), +16.2% YoY |
| Previous quarter EBITDA margin | 28.6% (-71 bps YoY) |
| Market cap | Rs. 11,805.07 Cr |
| CMP | Rs. 1,162.0 |
The Board of Directors will meet on Saturday, Oct 31, 2026, to approve unaudited standalone & consolidated results for the quarter and half-year ended Sep 30, 2026. The trading window, closed since Sep 25, 2026, reopens 48 hours after results declaration.
The Q2 FY27 earnings call is scheduled for Nov 2, 2026 at 10:00 AM IST, hosted by IIFL Capital. Participants include Dr. Ramesh Kancharla (Chairman & MD), Abrar Ali Dalal (Group CEO), Sudarshan Patodia (Group CFO) and Saurabh Bhandari (Head IR).
The central question for this quarter is whether Rainbow's margin slide — from 33.5% in Q2 FY26 to 28.6% in Q1 FY27 — stabilises as newly added hospitals mature, with management guiding a return to 24%-25% on a pre-Ind AS basis by the end of FY27. Growth momentum is strong: revenue rose 33.2% YoY in Q1 FY27 on capacity beds up 26% YoY to 2,435, IP discharges up 28% and ARPOB of Rs. 67,256 (+6% YoY), and the in-window additions of the Nellore acquisition (completed Aug 14, 2026) and the 50-bed Guntur hospital (commissioned Sep 16, 2026) add to the base. The swing factor is seasonality: management quantifies the seasonal uplift at ~8-10 percentage points of occupancy and ~12-14% of mature-hospital revenue in Q2/Q3, but the 2026 southwest monsoon ended at 87% of the long-period average with the South Peninsula — Rainbow's core region — at only 76% of LPA, and national dengue prints were near average, making the occupancy print versus the 52.0% of Q2 FY26 the key test of management's claim that seasonality has become 'the icing on the cake'. Execution remains the dominant narrative, with a five-year plan to add 2,500 beds to reach 5,000 beds at ~Rs. 2,200 Cr capex, ~Rs. 600 Cr budgeted for Pune, Coimbatore and Gurugram over FY27-FY29, and Indore commissioning guided for Q3 FY27. The Nov 2, 2026 call will be the first for new Group CFO Sudarshan Patodia, appointed Sep 23, 2026, so continuity of the guidance language — especially the pre-Ind AS margin framework — will itself be a focus.
Performance vs previously stated guidance: Management has a dense guidance dashboard; the Q2 print tests several of these directly.
Operating metric trajectory: Q2 is seasonally the strongest period, and the monsoon was in deficit.
Strategic execution / capex updates: Expansion execution since the last call has been rapid across Andhra Pradesh and beyond.
Leadership transition and disclosure items: The new Group CFO's first call adds a continuity angle.
Management attributes the margin step-down from 33.5% in Q2 FY26 to 28.6% in Q1 FY27 to the rapid expansion — almost 40% of current bed capacity was added over two years, creating 'temporary pressure on margins'. Management expects margins to strengthen as new hospitals mature and operating leverage improves, guiding a return to 24%-25% on a pre-Ind AS basis by the end of FY27.
The 2026 southwest monsoon ended at 87% of the long-period average — the lowest since 2015 — with the South Peninsula, Rainbow's core region, at only 76% of LPA. Seasonality contributes ~8-10 percentage points of occupancy and ~12-14% of mature-hospital revenue in Q2/Q3, so the seasonal uplift looks muted rather than strong, making the occupancy print the key test of management's claim of reduced dependence on seasonality.
The company is guiding to add 2,500 beds over five years to reach 5,000 beds at ~Rs. 2,200 Cr capex, with 1,200 beds already under development. Since the last call it completed the Nellore acquisition (Aug 14, 2026), commissioned a 50-bed Guntur hospital (Sep 16, 2026) and signed a 60-year Amaravati lease for a proposed 250-bed hospital (Sep 30, 2026), with Indore guided for Q3 FY27.
Sudarshan Patodia was appointed Group CFO effective Sep 23, 2026, succeeding Vikas Maheshwari who resigned effective Aug 31, 2026. His first earnings call is scheduled for Nov 2, 2026 at 10:00 AM IST, hosted by IIFL Capital.
Yes — consolidated revenue rose 33.2% YoY to Rs. 4,699.85 Mn in Q1 FY27, with growth accelerating from 6.5% in Q2 FY26 through 12% in Q3 and 24% in Q4 FY26. Growth was driven by balanced contributions from mature and newly commissioned hospitals, with capacity beds up 26% YoY to 2,435.